Hagel hearing reopens Senate wounds









WASHINGTON — Chuck Hagel, who was twice wounded as an enlisted soldier in Vietnam, came under withering attack Thursday as he battled former Republican colleagues in the Senate who sharply questioned whether he should be secretary of Defense.


In a daylong confirmation hearing notable for its raw emotion, Hagel was challenged to explain — and often to retract — earlier comments critical of Israel, his onetime skepticism of the nuclear threat from Iran, and perhaps most memorably, whether he could name a single "dumb" action the Senate had taken under pressure from the pro-Israel lobby.


Hagel, who appeared beleaguered at times, said he could not.





The spectacle often seemed more about Republicans publicly settling scores with the 66-year-old Nebraskan, who spent two terms in the Senate and retired in 2009. He grew increasingly estranged from his GOP colleagues after he began to criticize the war in Iraq, expressed doubts about use of force against Iran and lent support to Barack Obama in the 2008 presidential election.


Hagel sometimes stumbled answering the rapid-fire questions, at one point misstating — later correcting himself — the White House policy on preventing Iran from obtaining nuclear weapons.


He still appears likely to win confirmation by the full Senate, which has a Democratic majority.


If confirmed, Hagel would be the first Vietnam combat veteran to lead the Pentagon. The former Army sergeant, who spent 1967-68 fighting in the Mekong Delta, would inherit a Defense Department facing potentially drastic budget cuts, the withdrawal of U.S. troops from the war in Afghanistan, a growing debate over targeted killings by drone aircraft, an emerging conflict with insurgent groups in North Africa, the integration of women into direct ground combat roles, and other tasks.


But on Thursday, the battle over his nomination reopened contentious national security debates from years past. At times the session seemed more an inquisition than a typical confirmation hearing.


In the most striking example, Sen. John McCain, the Arizona Republican who lost to Obama in 2008, ripped into Hagel for his critique of the Iraq war, displaying how the bond forged between the former colleagues by their military service in Vietnam had been torn apart by another war.


"The question is, were you right or were you wrong?" McCain demanded, pressing Hagel on why he opposed President George W. Bush's decision to send 20,000 additional troops to Iraq in the so-called surge.


"I'm not going to give you a yes-or-no answer. I think its far more complicated than that," Hagel responded calmly. He said he would await the "judgment of history."


Glaring at Hagel, McCain ended the exchange with a bitter rejoinder: "I think history has already made a judgment about the surge, sir, and you are on the wrong side of it."


Hagel faced tough questioning even from Democrats on the Senate Armed Services Committee who have announced they intend to vote for him.


Sen. Carl Levin (D-Mich.), the committee chairman, took issue with what he called Hagel's "troubling" statements about Israel, his calls for direct talks with the militant group Hamas and his advocating against isolating Iran.


"While there is value in communicating with our adversaries, the formulation used by Sen. Hagel seemed to imply a willingness to talk to Iran on some issues that


I believe most would view


as nonnegotiable," Levin said.


When the hearing began, Hagel said he stood by his record in public service even as he urged lawmakers to look beyond his now-controversial votes and statements. He noted that he had cast thousands of votes during his Senate career and given hundreds of interviews and speeches.


"As you all know, I am on the record on many issues," he said. "But no one individual vote, no one individual quote, no one individual statement defines me, my beliefs, or my record."


Since his nomination last month, Hagel has clarified or apologized for several controversial statements. He also sought to rebut critics who warned he may not push hard enough to prevent Iran from obtaining nuclear weapons.





Read More..

Online bingo shows its worth at Rank






LONDON (Reuters) – It may lack the noisy camaraderie of a trip to the bingo hall, but the online version of the numbers game has proved more profitable for Britain‘s Rank Group than the original.


The merits of the online business were further emphasized when Rank said a snowy January had cost it 3 million pounds ($ 4.7 million) in revenue as Britons opted not to venture out to its bingo halls and casinos.






Operating profit from online bingo was 11.4 million pounds, just beating the 11.1 million earned from the venues themselves.


The company, majority owned by Malaysia’s Guoco, reported a 4 percent decline in pretax profit to 31.3 million pounds in the six months to December, with its loss-making Blue Square betting business proving a drag.


Many parts of Britain have seen heavy snow over the last two weeks and there are fears that the bad weather will hit economic activity and push the country back into recession.


Pub groups Enterprise Inns and Mitchell & Butlers both said the recent cold snap had hit sales.


“Allowing for the slow start to the second half we remain confident in our prospects for the remainder of the year and in our longer-term growth strategy,” Rank Chief Executive Ian Burke said.


Rank’s main activities are in Britain where it runs 35 Grosvenor Casinos and more than 100 Mecca bingo clubs.


Profits growth in its online bingo business mirrors that in the gambling industry as a whole where online betting is the fastest growing part of the market, helped by the popularity of smart phones and tablets.


However, Rank has said it is reviewing the future of its own struggling online betting business Blue Square, a relative minnow in a crowded sector.


“We felt the losses were not losses we could continue to sustain,” said Burke.


Blue Square reported an operating loss of 4.8 million pounds in the six months and Rank has now cut its spending on marketing the business.


“There were 11 or 12 competitors advertising and that spending just wasn’t cutting through,” said Burke.


He declined to comment further on the future of the business pending completion of the review.


Rank is awaiting regulatory clearance for a planned 205 million pound deal to buy the casino business of Gala Coral.


A preliminary report by the Competition Commission said Rank could have to sell six casinos to get the deal approved.


($ 1 = 0.6332 British pounds)


(Editing by Louise Ireland and Brenda Goh)


Internet News Headlines – Yahoo! News





Title Post: Online bingo shows its worth at Rank
Url Post: http://www.news.fluser.com/online-bingo-shows-its-worth-at-rank/
Link To Post : Online bingo shows its worth at Rank
Rating:
100%

based on 99998 ratings.
5 user reviews.
Author: Fluser SeoLink
Thanks for visiting the blog, If any criticism and suggestions please leave a comment




Read More..

Appeals judges: Anti-paparazzi law appears legal


LOS ANGELES (AP) — An appeals panel says California's anti-paparazzi statute appears to be constitutional based on a brief filed by prosecutors.


A preliminary statement by three judges in Los Angeles requires a judge who dismissed charges aimed at a paparazzo who authorities say was driving recklessly to review his order. The judge may stick to his ruling, which would trigger a full appeal, or he could schedule further arguments on the case against freelance photographer Paul Raef.


Raef was the first person charged under the new law after a high-speed chase involving Justin Bieber last year.


Superior Court Judge Thomas Rubinson dismissed two charges in November, ruling the law is too broad and is unconstitutional.


Raef's attorney David S. Kestenbaum says he is asking Rubinson to stand by his ruling and allow a full appeal.


Read More..

Hip Implant’s Risks Inadequately Assessed, DePuy Report Found in 2010


A review conducted internally by Johnson & Johnson soon after it recalled a troubled hip implant found that the company had not adequately assessed the device’s potential risks before it was used in more than 90,000 patients, court testimony on Thursday showed.


The engineering report, which was done in 2010, also found that Johnson & Johnson’s orthopedic unit had used inadequate or incorrect standards in trying to assess some of those risks before first selling the implant in 2003. The device at issue — the Articular Surface Replacement, or A.S.R. — proved to be among the most flawed orthopedic devices sold in recent decades.


The report was introduced on Thursday in Los Angeles Superior Court, in the first A.S.R.-related lawsuit to go to trial against the DePuy Orthopaedics division of Johnson & Johnson. More than 10,000 similar lawsuits have been filed in the United States.


In videotaped testimony shown in court, Jimmy Smith, a compliance manager at DePuy, was asked about the report, and he said it indicated that company officials had not used appropriate engineering controls to try to anticipate the device’s problems.


“They did their job, but they could have done it better,” Mr. Smith said.


Separately, a DePuy engineer, Graham Isaac, testified on Thursday that before selling the A.S.R., the company only tested its performance on laboratory equipment at one angle of implantation.


Depending on the surgical technique and a patient’s build, orthopedic surgeons can implant the cup component of an artificial hip at a variety of angles. And because the A.S.R. had a design flaw, normal variance from the single angle at which DePuy had tested it made it more likely for the joint’s cup and ball components to strike each other, releasing metallic debris inside a patient.


DePuy conducted the post-mortem review of the A.S.R. in November 2010, just three months after it recalled the all-metal implant, but it never released the analysis. It also, apparently, did not conduct a similar review in response to the mounting number of complaints about the device that it received from doctors and others in 2008 and 2009.


Lorie Gawreluk, a spokeswoman for DePuy, said that she could not comment on any details of the lawsuit, but that the company believed that the evidence would show it acted appropriately. The trial’s proceedings were monitored over the Courtroom View Network.


The A.S.R. is projected to fail within five years in about 40 percent of patients who received the implant. That early failure rate, which is expected to grow over time, is many times higher than the failure rate for most hip replacements.


In the post-recall review in 2010, DePuy engineers examined the criteria and “controls,” or standards, that were used nearly a decade earlier when company officials tried to anticipate how the A.S.R. might perform. Because the version of the device that was sold in the United States was never clinically tested in patients, officials used the controls to assess the implant.


Among other things, DePuy officials failed to anticipate that the A.S.R. would have a high rate of wear as a patient moved, even though the control referenced in the device’s records demonstrated “that the product is more likely to experience contact between the head and rim” than competing implants.


In previously recorded testimony presented in court on Wednesday, DePuy’s president, Andrew Ekdahl, was shown an e-mail in which he was warned about the A.S.R.’s problems nearly three years before it was recalled.


Mr. Ekdahl and other DePuy executives have asserted that they acted properly and in a timely fashion to the device’s problems. The company spokeswoman, Ms. Gawreluk, said Mr. Ekdahl would not be made available for an interview.


Read More..

Are razor blade makers just ensuring a big cut?








We can put men on the moon. We can make computers small enough to carry around in our pockets. But we can't make a razor blade that stays sharp longer than a week?


It sounds trivial. But the utter lack of progress on the razor front raises fundamental questions about America's industrial might.


Has the sun set on the age of innovation in this country? Is it possible that American ingenuity has met its match in a relatively modest personal-hygiene product used by millions of consumers?






Or are the likes of Gillette and Schick, which account for about 90% of the replacement-blade market, conspiring to keep razor advances off the shelf to deliberately fleece customers and maintain multibillion-dollar revenue streams?


Either way you look at it, it's not a terribly flattering portrayal of U.S. business.


The global market for all shaving products is forecast to top $33 billion by 2015, according to Global Industry Analysts, a market researcher.


Procter & Gamble's Gillette, the market leader, estimates that about two-thirds of American guys age 15 and older shave with a razor, representing a U.S. market for razors and blades worth more than $2.4 billion a year. Worldwide, that market is more than $14 billion.


Schick says most men shave at least three times a week. Razor-Gator.com, a shaving-related website, figures that a man devotes roughly 3,300 hours of his life to shaving.


With those numbers in mind, you'd think teams of engineers would be busy improving the ways and means of a good shave. For example, water causes corrosion on blades, which contributes to making them dull. Isn't there an alloy, or a coating, to address that?


Moore's Law famously predicted that computer chips will double in processing power every couple of years or so. The result has been breakneck advances in the technology field. The first iPhone was introduced just six years ago, for instance, and we're already up to the iPhone 5.


Oh sure, Gillette and Schick keep adding more features. Gillette says its battery-operated Fusion ProGlide razor "delivers soothing micropulses." Schick says its Hydro Power Select boasts "three vibration settings, easy-to-read indicators and a one-touch control button, allowing men to interact with their razor in a new way."


Micropulses, vibration settings — this they can do. But they can't come up with a blade that stays sharp more than a few days?


"Sure they can," said Jeff Grant, president of Coating Services Group, a Lakeside company that makes scalpels for medical use and thus knows a thing or two about sharp edges. "They could make a ceramic blade that maybe costs $100 and lasts for years."


Well, that sounds good. An eight-pack of Gillette Mach3 Turbo shaving cartridges — one of the more popular razors — runs $24 at Walgreens. If you figure on changing the cartridge once a week, that would mean spending $156 each year on razor blades.


So, yeah, I'd spend $100 for a blade that lasts for two, three or more years.


And that, Grant told me, is exactly why we'll never be offered such a chance by Gillette or Schick.


"They'd sell you one blade and they'd be done," he said. "It's a business decision."


Susan Baba, a Gillette spokeswoman, told me she hadn't heard about any research into ceramic razor blades. But she said the company is dedicated to "figuring out the next stage of razors."


As for the longevity of current blades, Baba said you can't generalize. Some people make a blade last a few days, others can go months without changing cartridges.


"It all depends on the length of your hair, how often you shave, how many strokes you use," Baba said.






Read More..

Giffords testifies at heated Senate hearing on gun control









WASHINGTON — "Speaking is difficult, but I need to say something important," former Rep. Gabrielle Giffords told her onetime colleagues. "Violence is a big problem. Too many children are dying. Too many children. We must do something.


"It would be hard, but the time is now. You must act."


Her words, read from a single, handwritten page, were among the camera-ready scenes as the Senate began hearings on gun control Wednesday, in a charged atmosphere with each side reaching for emotional force.





The former congresswoman, still severely disabled after being shot in the head two years ago at an outdoor appearance in her Tucson district, spoke for barely a minute, breaking the traditional protocol that calls for senators to make opening statements before witnesses give testimony.


Then she made her way from the room, leaving behind her husband, retired Navy Capt. Mark E. Kelly, a former space shuttle astronaut. In a reminder of the pervasiveness of gun violence in this country, Kelly informed senators that three people had just been wounded by a gunman at an office building in Phoenix. (At least one of the victims later died.)


At the opposite end of a long, polished table sat the lead witness for the opposing side, National Rifle Assn. Executive Vice President Wayne LaPierre. He and Kelly barely interacted save for a brief handshake at the hearing's close.


The space between the two could have served as a metaphor for much of the hearing, where the formal politeness of the Senate Judiciary Committee hearing room did little to mask the continued wide division over gun legislation.


Democrats called for stronger laws to limit the sale of guns; Republicans insisted that existing laws were being under-enforced and questioned the need for new ones.


The shootings in Tucson and Newtown, Conn., where 20 first-graders were killed last month, "are terrible tragedies," said the senior Republican on the panel, Iowa Sen. Charles E. Grassley, but they "should not be used to put forward every gun control measure that has been floating around for years."


Off stage, some senators have begun to move toward agreement on at least one part of the gun package pushed by President Obama — a measure to tighten the system of background checks for gun purchases.


Sen. Charles E. Schumer (D-N.Y.), who is crafting a background checks bill, announced at the hearing that he was "having productive conversations with colleagues on both sides of the aisle, including a good number with high NRA ratings."


That agreement does not extend to the NRA itself, as LaPierre made clear.


"Law-abiding gun owners will not accept blame for the acts of violent or deranged criminals," he said.


Later, he specifically rejected the idea of universal background checks for gun purchases. "My problem with background checks is you're never going to get criminals to go through universal background checks," he said, prompting a heated exchange with Illinois Sen. Richard J. Durbin.


"Mr. LaPierre, that's the point," Durbin interjected. "The criminals won't go to purchase the guns, because there will be a background check. We'll stop them from the original purchase."


LaPierre was more amenable to prosecution of straw purchasers — people who buy guns for others, often those prohibited from buying firearms themselves. Judiciary Committee Chairman Patrick J. Leahy (D-Vt.) and Durbin introduced a bill last week to combat gun trafficking. Sens. Mark Steven Kirk (R-Ill.) and Kirsten Gillibrand (D-N.Y.) unveiled another gun trafficking proposal Wednesday.


While prospects for expanded background checks and tougher trafficking laws have grown, the prospects for an assault weapons ban, eagerly sought by some gun control advocates, seem dim.


Leahy notably did not endorse the ban in his comments during the hearing. Nor did Kelly, who instead called for a "careful and civil conversation about the lethality of firearms we permit to be legally bought and sold in this country" while reminding senators of the toll that mass shootings have taken.


"Gabby's gift for speech is a distant memory," Kelly said, referring to his wife by her nickname. "She struggles to walk, and she is partially blind." But, he added, "we aren't here as victims. We're speaking to you today as Americans."


He and Giffords "have our firearms for the same reasons that millions of others have guns, for hunting and target shooting," he said. "But rights demand responsibility." After the hearing, Giffords and Kelly met with Obama at the White House.





Read More..

Rape trial of teenaged football players to be open to public: Ohio judge






(Reuters) – The controversial trial of two high school football players accused of raping a classmate will remain open to the public and will not be relocated to another town, an Ohio judge ruled on Wednesday.


Prosecutors and an attorney representing the accuser had sought a closed trial, arguing that public access to the juvenile trial would subject the accuser to unwanted publicity and make potential witnesses reluctant to testify.






Visiting Hamilton County Judge Tom Lipps said the presence of the media would prevent inaccurate reporting and enhance public confidence in the juvenile justice system, according to his written ruling, a copy of which was seen by Reuters.


“An open hearing is especially valuable where rumors, mischaracterizations and opinions unsupported by facts have reportedly been repeated in social media postings and other published outlets,” Lipps wrote. “An open hearing will diminish the influence of such postings and publications.”


Prosecutors have accused Ma’Lik Richmond and Trent Mays, both 16, of raping a classmate at a party attended by many teammates last August in Steubenville, a close-knit city of 19,000 near the Pennsylvania border.


The case attracted national attention after the hacker activist group Anonymous publicized a picture of two young men carrying a girl by her wrists and ankles and released a video showing other young men joking about the alleged assault.


Richmond’s lawyer, Walter Madison, said previously on CNN that his client was one of the young men in the photograph – which he said was taken out of context – but does not appear in the video. A lawyer for Mays has not publicly commented on the postings.


Community leaders have accused authorities of protecting the school’s popular football program by not charging more players who could have prevented the alleged attack.


Lipps also ruled on Wednesday that the trial will remain in Steubenville. He set a trial date for March 13.


Reuters generally does not identify people who say they have been victims of sex crimes.


(Editing by Paul Thomasch, Bernard Orr)


Internet News Headlines – Yahoo! News





Title Post: Rape trial of teenaged football players to be open to public: Ohio judge
Url Post: http://www.news.fluser.com/rape-trial-of-teenaged-football-players-to-be-open-to-public-ohio-judge/
Link To Post : Rape trial of teenaged football players to be open to public: Ohio judge
Rating:
100%

based on 99998 ratings.
5 user reviews.
Author: Fluser SeoLink
Thanks for visiting the blog, If any criticism and suggestions please leave a comment




Read More..

Patty Andrews of Andrews Sisters dead at 94


LOS ANGELES (AP) — Patty Andrews, the last surviving member of the singing Andrews Sisters trio whose hits such as the rollicking "Boogie Woogie Bugle Boy of Company B" and the poignant "I Can Dream, Can't I?" captured the home-front spirit of World War II, died Wednesday. She was 94.


Andrews died of natural causes at her home in the Los Angeles suburb of Northridge, said family spokesman Alan Eichler in a statement.


Patty was the Andrews in the middle, the lead singer and chief clown, whose raucous jitterbugging delighted American servicemen abroad and audiences at home.


She could also deliver sentimental ballads like "I'll Be with You in Apple Blossom Time" with a sincerity that caused hardened GIs far from home to weep.


"When I was a kid, I only had two records and one of them was the Andrews Sisters. They were remarkable. Their sound, so pure," said Bette Midler, who had a hit cover of "Bugle Boy" in 1973. "Everything they did for our nation was more than we could have asked for. This is the last of the trio, and I hope the trumpets ushering (Patty) into heaven with her sisters are playing "Boogie Woogie Bugle Boy."


From the late 1930s through the 1940s, the Andrews Sisters produced one hit record after another, beginning with "Bei Mir Bist Du Schoen" in 1937 and continuing with "Beat Me Daddy, Eight to the Bar," ''Rum and Coca-Cola" and more. They recorded more than 400 songs and sold over 80 million records, several of them going gold.


Other sisters, notably the Boswells, had become famous as singing acts, but mostly they huddled before a microphone in close harmony. The Andrews SistersLaVerne, Maxene and Patty — added a new dimension. During breaks in their singing, they cavorted about the stage in rhythm to the music.


Their voices combined with perfect synergy. As Patty remarked in 1971: "There were just three girls in the family. LaVerne had a very low voice. Maxene's was kind of high, and I was between. It was like God had given us voices to fit our parts."


Kathy Daris of the singing Lennon Sisters recalled on Facebook late Wednesday that the Andrews Sisters "were the first singing sister act that we tried to copy. We loved their rendition of songs, their high spirit, their fabulous harmony."


The Andrews Sisters' rise coincided with the advent of swing music, and their style fit perfectly into the new craze. They aimed at reproducing the sound of three harmonizing trumpets.


"I was listening to Benny Goodman and to all the bands," Patty once remarked. "I was into the feel, so that would go into my own musical ability. I was into swing. I loved the brass section."


Unlike other singing acts, the sisters recorded with popular bands of the '40s, fitting neatly into the styles of Benny Goodman, Glenn Miller, Jimmy Dorsey, Bob Crosby, Woody Herman, Guy Lombardo, Desi Arnaz and Russ Morgan. They sang dozens of songs on records with Bing Crosby, including the million-seller "Don't Fence Me In." They also recorded with Dick Haymes, Carmen Miranda, Danny Kaye, Al Jolson, Jimmy Durante and Red Foley.


The Andrews' popularity led to a contract with Universal Pictures, where they made a dozen low-budget musical comedies between 1940 and 1944. In 1947, they appeared in "The Road to Rio" with Bing Crosby, Bob Hope and Dorothy Lamour.


The trio continued until LaVerne's death in 1967. By that time the close harmony had turned to discord, and the sisters had been openly feuding.


Midler's cover of "Bugle Boy" revived interest in the trio. The two survivors joined in 1974 for a Broadway show, "Over Here!" It ran for more than a year, but disputes with the producers led to the cancellation of the national tour of the show, and the sisters did not perform together again.


Patty continued on her own, finding success in Las Vegas and on TV variety shows. Her sister also toured solo until her death in 1995.


Her father, Peter Andrews, was a Greek immigrant who anglicized his name of Andreus when he arrived in America; his wife, Olga, was a Norwegian with a love of music. LaVerne was born in 1911, Maxine (later Maxene) in 1916, Patricia (later Patty, sometimes Patti) in 1918.


All three sisters were born and raised in the Minneapolis area, spending summers in Mound, Minn., on the western shores of Lake Minnetonka, about 20 miles west of Minneapolis.


Listening to the Boswell Sisters on radio, LaVerne played the piano and taught her sisters to sing in harmony; neither Maxene nor Patty ever learned to read music. All three studied singers at the vaudeville house near their father's restaurant. As their skills developed, they moved from amateur shows to vaudeville and singing with bands.


After Peter Andrews moved the family to New York in 1937, his wife, Olga, sought singing dates for the girls. They were often turned down with comments such as: "They sing too loud and they move too much." Olga persisted, and the sisters sang on radio with a hotel band at $15 a week. The broadcasts landed them a contract with Decca Records.


They recorded a few songs, and then came "Bei Mir Bist Du Schoen," an old Yiddish song for which Sammy Cahn and Saul Kaplan wrote English lyrics. (The title means, "To Me You Are Beautiful.") It was a smash hit, and the Andrews Sisters were launched into the bigtime.


Their only disappointment was the movies. Universal was a penny-pinching studio that ground out product to fit the lower half of a double bill. The sisters were seldom involved in the plots, being used for musical interludes in film with titles such as "Private Buckaroo," ''Swingtime Johnny" and "Moonlight and Cactus."


Their only hit was "Buck Privates," which made stars of Abbott and Costello and included the trio's blockbuster "Boogie Woogie Bugle Boy from Company B."


In 1947, Patty married Martin Melcher, an agent who represented the sisters as well as Doris Day, then at the beginning of her film career. Patty divorced Melcher in 1949 and soon he became Day's husband, manager and producer.


Patty married Walter Weschler, pianist for the sisters, in 1952. He became their manager and demanded more pay for himself and for Patty. The two other sisters rebelled, and their differences with Patty became public. Lawsuits were filed between the two camps.


"We had been together nearly all our lives," Patty explained in 1971. "Then in one year our dream world ended. Our mother died and then our father. All three of us were upset, and we were at each other's throats all the time."


Patty Andrews is survived by her foster daughter, Pam DuBois, a niece and several cousins. Weschler died in 2010.


A memorial service is planned in Los Angeles, with the date to be determined.


Read More..

During Trial, New Details Emerge on DuPuy Hip





When Johnson & Johnson announced the appointment in 2011 of an executive to head the troubled orthopedics division whose badly flawed artificial hip had been recalled, the company billed the move as a fresh start.




But that same executive, it turns out, had supervised the implant’s introduction in the United States and had been told by a top company consultant three years before the device was recalled that it was faulty.


In addition, the executive also held a senior marketing position at a time when Johnson & Johnson decided not to tell officials outside the United States that American regulators had refused to allow sale of a version of the artificial hip in this country.


The details about the involvement of the executive, Andrew Ekdahl, with the all-metal hip implant emerged Wednesday in Los Angeles Superior Court during the trial of a patient lawsuit against the DePuy Orthopaedics division of Johnson & Johnson. More than 10,000 lawsuits have been filed against DePuy in connection with the device — the Articular Surface Replacement, or A.S.R. — and the Los Angeles case is the first to go to trial.


The information about the depth of Mr. Ekdahl’s involvement with the implant may raise questions about DePuy’s ability to put the A.S.R. episode behind it.


Asked in an e-mail why the company had promoted Mr. Ekdahl, a DePuy spokeswoman, Lorie Gawreluk, said the company “seeks the most accomplished and competent people for the job.”


On Wednesday, portions of Mr. Ekdahl’s videotaped testimony were shown to jurors in the Los Angeles case. Other top DePuy marketing executives who played roles in the A.S.R. development are expected to testify in coming days. Mr. Ekdahl, when pressed in the taped questioning on whether DePuy had recalled the A.S.R. because it was unsafe, repeatedly responded that the company had recalled it “because it did not meet the clinical standards we wanted in the marketplace.”


Before the device’s recall in mid-2010, Mr. Ekdahl and those executives all publicly asserted that the device was performing extremely well. But internal documents that have become public as a result of litigation conflict with such statements.


In late 2008, for example, a surgeon who served as one of DePuy’s top consultants told Mr. Ekdahl and two other DePuy marketing officials that he was concerned about the cup component of the A.S.R. and believed it should be “redesigned.” At the time, DePuy was aggressively promoting the device in the United States as a breakthrough and it was being implanted into thousands of patients.


“My thoughts would be that DePuy should at least de-emphasize the A.S.R. cup while the clinical results are studied,” that consultant, Dr. William Griffin, wrote.


A spokesman for Dr. Griffin said he was not available for comment.


The A.S.R., whose cup and ball components were both made of metal, was first sold by DePuy in 2003 outside the United States for use in an alternative hip replacement procedure called resurfacing. Two years later, DePuy started selling another version of the A.S.R. for use here in standard hip replacement that used the same cup component as the resurfacing device. Only the standard A.S.R. was sold in the United States; both versions were sold outside the country.


Before the device recall in mid-2010, about 93,000 patients worldwide received an A.S.R., about a third of them in this country. Internal DePuy projections estimate that it will fail in 40 percent of those patients within five years; a rate eight times higher than for many other hip devices.


Mr. Ekdahl testified via tape Wednesday that he had been placed in charge of the 2005 introduction of the standard version of the A.S.R. in this country. Within three years, he and other DePuy executives were receiving reports that the device was failing prematurely at higher than expected rates, apparently because of problems related to the cup’s design, documents disclosed during the trial indicate.


Along with other DePuy executives, he also participated in a meeting that resulted in a proposal to redesign the A.S.R. cup. But that plan was dropped, apparently because sales of the implant had not justified the expense, DePuy documents indicate.


In the face of growing complaints from surgeons about the A.S.R., DePuy officials maintained that the problems were related to how surgeons were implanting the cup, not from any design flaw. But in early 2009, a DePuy executive wrote to Mr. Ekdahl and other marketing officials that the early failures of the A.S.R. resurfacing device and the A.S.R. traditional implant, known as the XL, were most likely design-related.


“The issue seen with A.S.R. and XL today, over five years post-launch, are most likely linked to the inherent design of the product and that is something we should recognize,” that executive, Raphael Pascaud wrote in March 2009.


Last year, The New York Times reported that DePuy executives decided in 2009 to phase out the A.S.R. and sell existing inventories weeks after the Food and Drug Administration asked the company for more safety data about the implant.


The F.D.A. also told the company at that time that it was rejecting its efforts to sell the resurfacing version of the device in the United States because of concerns about “high concentration of metal ions” in the blood of patients who received it.


DePuy never disclosed the F.D.A. ruling to regulators in other countries where it was still marketing the resurfacing version of the implant.


During a part of that period, Mr. Ekdahl was overseeing sales in Europe and other regions for DePuy. When The Times article appeared last year, he issued a statement, saying that any implication that the F.D.A. had determined there were safety issues with the A.S.R. was “simply untrue.” “This was purely a business decision,” Mr. Ekdahl stated at that time.


This article has been revised to reflect the following correction:

Correction: January 30, 2013

An earlier version of this article, in the summary, described the start of the DePuy trial incorrectly. It began last week, not this week.



Read More..

Avery Dennison to sell business units for $500 million









Avery Dennison Corp. has agreed to sell two of its businesses for $500 million in cash to CCL Industries Inc., a Canadian maker of specialty packaging, the Pasadena company said.


The proposed sale announced Wednesday comes three months after Minnesota-based 3M abandoned its plans to purchase Avery Dennison's office and consumer products unit. The U.S. Department of Justice had opposed that deal because of antitrust concerns.


Now, Toronto-based CCL has agreed to acquire the unit, which had sales of $730 million in 2012. The division's products include Hi-Liters and Marks-A-Lot markers as well as binders. CCL also agreed to acquire Avery's designed and engineered solutions division, which makes pressure-sensitive labels for packaging and posted 2012 sales of $180 million.





"CCL is one of our largest customers, and we have a long-standing relationship with them," said Avery Dennison Chief Executive Dean A. Scarborough. "We are pleased that they will become the steward of the Avery brand for office products."


Quiz: How much do you know about California's economy?


The transaction, expected to close this year if approved by regulators, would be CCL's largest acquisition.


"This acquisition has the potential to transform our company at many levels," said Geoffrey Martin, chief executive of CCL.


Avery Dennison on Wednesday also reported fourth-quarter net income of $49 million, or 48 cents a share, up from $22.2 million, or 21 cents, a year earlier. Excluding certain items, earnings were 54 cents a share compared with the 48 cents expected by analysts. Sales rose 5.3% to $1.53 billion.


Avery Dennison shares rose $2.30, or 6.4%, to $38.44.


ricardo.lopez2@latimes.com





Read More..